Comparative Analysis and Thoughts Based on the Internationalized Case of Traditional Chinese Medicine  

作　　者：TANG Haitao HUANG Wenlong MA Jimei LIU Li 

机构地区：[1]China Pharmaceutical University [2]Jiangsu Suzhong Pharmaceutical Group Co.,Ltd.

出　　处：《Journal of Medicines Development Sciences》2018年第1期46-50,共5页药物发展科学期刊

摘　　要：With the increasing recognition of TCM (traditional Chinese medicine) from people thanks to its characteristics and merits,more and more countries are beginning to pay close attention to the development and application of TCM.Though TCM has been spread to numerous countries and regions,only a few TCM drugs have been registered as medications in the mainstream markets in Europe and the U.S.,which are also the important overseas markets in the global ambition of TCM enterprises from China.By selecting typical cases and,in particular,studying the cases of Tasly Compound Danshen Dripping Pills entering the U.S.market and Di’ao Xinxuekang Capsule entering the EU market,this paper compares the processes and experience of TCM registration in the form of vegetable drug in the U.S.and the EU in order to provide practical and feasible references for TCM to attempt the EU and U.S.markets.

关 键 词：TCM INTERNATIONALIZATION CASE study registration OVERSEAS MARKETS 

分 类 号：R[医药卫生]